Pharmabiz29m
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:15 Hrs [IST] Dozee, India’s health A ...
Pharmabiz44m
Ascentage Pharma gets China NMPA nod to start registrational phase III studies of APG-2449 to for treat patients with NSCLC
Rockville, Maryland Wednesday, October 9, 2024, 16:00 Hrs [IST] ...
Pharmabiz1h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz2h
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy: Jakarta, Indonesia Wednesday, October 9, 2024, 14:30 Hrs [IST] Roy ...
Pharmabiz2h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz3h
The Roquette Foundation for Health announces the winner of its 3rd Research Prize in the field of health prevention
The Roquette Foundation for Health has awarded its 3rd Research Prize to scientist Delphine Payros and her team, for their work on the toxicity of multiple dietary exposures involving mycotoxins in ...
Pharmabiz4h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz5h
Merck’s phase 3 KEYNOTE-689 trial of anti-PD-1 therapy, Keytruda to treat LA-HNSCC meets its primary endpoint of event-free survival
Rahway, New Jersey Wednesday, October 9, 2024, 11:00 Hrs [IST] ...
Pharmabiz6h
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test: Maryland Wednesday, October 9, 2024, 10:00 Hrs [IST] The US Food and Drug Administratio ...
Pharmabiz7h
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health., announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ...
Pharmabiz8h
SA Ramesh has been elected president of TNCDA; KK Selvan secretary
SA Ramesh has been elected president of TNCDA; KK Selvan secretary: Peethaambaran Kunnathoor, Chennai Wednesday, October 9, ...
Pharmabiz8h
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization: Nandita Vijayasimha, Bengaluru Wednesday, October 9, 2024, 08:00 Hrs [IST] ...